1Wood C,González EA,Martin KJ.Challenges in the therapy of secondary hyperparathyroidism.Ther Apher Dial,2005,9 (1):4-8.
2Tominaga Y,Matsuoka S,Sato T.Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease.Ther Apher Dial,2005,9(1):44-47.
4Goodman WG,Jüppner H,Salusky IB,et al.Parathyroid hormone (PTH),PTH-derived peptides,and new PTH assays in renal osteodystrophy.Kidney Int,2003,63:1-11.
5Brossard JH,Yamamoto LN,D'Amour P.PTH metabolites in renal failure:bioactiveity and clinical implications.Semin Dial,2002,15(3):196-201.
6D'Amour P,Brossard JH,Rousseau L,et al.Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.Kidney Int,2005,68:998-1007.
7Yamashita H,Gao P,Cantor T,et al.Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism.Surgery,2004,135:149-156.
8Cantor TL.The opposing actions of the two parathyroid hormones,1-84PTH and 7-84PTH:improvement in renal bone and calcium metabolism management.Hemodialysis Int,2004,8:372-385.
9Goodman WG.The evolution of assays for parathyroid hormone.Semin Dial,2005,18(4):296-301.
10Sawaya BP,Butros R,Naqvi S,et al.Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.Kidney Int,2003,64 (2):737-742.
